Eligo Bioscience

Eligo Bioscience focuses on in vivo gene editing to treat diseases linked to microbiomes

Biotech & Life Sciences

Sector

Seed

Stage

Biotechnology

Model

01Company Overview

Eligo Bioscience focuses on in vivo gene editing to treat diseases linked to microbiomes. The company targets conditions with high unmet medical needs.

02Backed By1 investor

SPSeventure Partners→

03Similar Companies

CM

Is this your company? Claim your profile

Chroma Medicine

Biotech & Life Sciences

→

SB

Singular Bio

Biotech & Life Sciences

→

BT

Base Therapeutics

Biotech & Life Sciences

→

CT

CRISPR Therapeutics

Biotech & Life Sciences

→

A

A-SEEDS

Biotech & Life Sciences

→

04Startup DNA

8

signals

Sectors
Business Model
Technology